2020
Development of an Operative Trauma Course in Uganda—A Report of a Three-Year Experience
Ullrich SJ, DeWane MP, Cheung M, Fleming M, Namugga MM, Fu W, Kurigamba G, Kabuye R, Mabweijano J, Galukande M, Ozgediz D, Pei KY. Development of an Operative Trauma Course in Uganda—A Report of a Three-Year Experience. Journal Of Surgical Research 2020, 256: 520-527. PMID: 32799000, DOI: 10.1016/j.jss.2020.07.024.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultChildChild, PreschoolClinical CompetenceCurriculumFemaleHealth ResourcesHumansInjury Severity ScoreInterdisciplinary PlacementInternship and ResidencyMaleMiddle AgedSurgeonsSurgical Procedures, OperativeSurveys and QuestionnairesTraumatologyTreatment OutcomeUgandaWounds and InjuriesYoung AdultConceptsOperative techniqueTrauma courseInitial patient evaluationThree-year experienceLow-resource settingsHealth care systemBedside interventionsRoad traffic crashesPatient demographicsClinical outcomesPatient evaluationLiver repairHead CTLeading causePractice patternsDiagnostic imagingLow-income countriesSecond-year surgical residentsStudy periodCare systemResident practiceSurgical residentsLaparotomySignificant differencesPatients
2009
Hybrid surgical and endovascular therapy in multifocal peripheral TASC D lesions: up to three-year follow-up.
Nishibe T, Kondo Y, Dardik A, Muto A, Koizumi J, Nishibe M. Hybrid surgical and endovascular therapy in multifocal peripheral TASC D lesions: up to three-year follow-up. The Journal Of Cardiovascular Surgery 2009, 50: 493-9. PMID: 19734834.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overAngioplasty, BalloonArterial Occlusive DiseasesCombined Modality TherapyConstriction, PathologicEndarterectomyFemaleFemoral ArteryHemodynamicsHumansIliac ArteryIschemiaKaplan-Meier EstimateLimb SalvageLower ExtremityMaleMiddle AgedPeripheral Vascular DiseasesRadiographyReoperationStentsTime FactorsTreatment OutcomeVascular PatencyConceptsCommon femoral artery endarterectomyFemoral artery endarterectomyTASC D lesionsLimb salvage ratePrimary patency rateCritical limb ischemiaPeripheral artery diseaseCommon femoral arteryEndovascular therapySuperficial femoral arteryFemoral arteryPatency ratesArtery endarterectomyIntermittent claudicationArtery diseaseD lesionsLimb ischemiaSalvage rateLower limbsSurvival rateAssisted primary patencyVascular Surgery guidelinesThree-year experienceHemodynamic successPrimary patency
1992
A THREE-YEAR EXPERIENCE WITH SERUM ANODAL TRYPSINOGEN AS A BIOCHEMICAL MARKER FOR REJECTION IN PANCREATIC ALLOGRAFTS
PERKAL M, MARKS C, LORBER M, MARKS W. A THREE-YEAR EXPERIENCE WITH SERUM ANODAL TRYPSINOGEN AS A BIOCHEMICAL MARKER FOR REJECTION IN PANCREATIC ALLOGRAFTS. Transplantation 1992, 53: 415-419. PMID: 1371196, DOI: 10.1097/00007890-199202010-00028.Peer-Reviewed Original ResearchConceptsPancreatic allograftsSPK recipientsAcute rejectionBiochemical markersWhole organ pancreas transplantationClinical diagnosisPrevious kidney transplantSerial serum samplesType I diabeticsThree-year experienceAllograft survivalGraft biopsyGraft duodenumPancreatic rejectionGraft pancreatitisPancreas transplantationKidney transplantOutlet obstructionSerum creatinineAdditional patientsImmunosuppressive agentsDirect traumaPresumptive diagnosisCreatinine valuesAmylase output
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply